The Effects of CSF Neurogranin and APOE ε4 on Cognition and Neuropathology in Mild Cognitive Impairment and Alzheimer’s Disease

Cerebrospinal fluid (CSF) measurements of neurogranin (Ng) have emerged as a promising biomarker for cognitive decline in mild cognitive impairment (MCI) and Alzheimer’s disease (AD). The apolipoprotein E ε4 (APOE ε4) allele is by far the most consistent genetic risk factor for AD. However, it is no...

תיאור מלא

מידע ביבליוגרפי

Principais autores:	Yulan Fan, Ying Gao, Joseph Therriault, Jing Luo, Maowen Ba, Hua Zhang, the Alzheimer’s Disease Neuroimaging Initiative
פורמט:	Artigo
שפה:	Inglês
יצא לאור:	Frontiers Media S.A. 2021-04-01
סדרה:	Frontiers in Aging Neuroscience
נושאים:	Alzheimer’s disease apolipoprotein E ε4 mild cognitive impairment neurogranin cerebrospinal fluid
גישה מקוונת:	https://www.frontiersin.org/articles/10.3389/fnagi.2021.667899/full
תגים:	הוספת תג אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!